Drug-target binding affinity prediction based on power graph and word2vec.

IF 2.1 4区 医学 Q3 GENETICS & HEREDITY
Jing Hu, Shuo Hu, Minghao Xia, Kangxing Zheng, Xiaolong Zhang
{"title":"Drug-target binding affinity prediction based on power graph and word2vec.","authors":"Jing Hu, Shuo Hu, Minghao Xia, Kangxing Zheng, Xiaolong Zhang","doi":"10.1186/s12920-024-02073-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Drug and protein targets affect the physiological functions and metabolic effects of the body through bonding reactions, and accurate prediction of drug-protein target interactions is crucial for drug development. In order to shorten the drug development cycle and reduce costs, machine learning methods are gradually playing an important role in the field of drug-target interactions.</p><p><strong>Results: </strong>Compared with other methods, regression-based drug target affinity is more representative of the binding ability. Accurate prediction of drug target affinity can effectively reduce the time and cost of drug retargeting and new drug development. In this paper, a drug target affinity prediction model (WPGraphDTA) based on power graph and word2vec is proposed.</p><p><strong>Conclusions: </strong>In this model, the drug molecular features in the power graph module are extracted by a graph neural network, and then the protein features are obtained by the Word2vec method. After feature fusion, they are input into the three full connection layers to obtain the drug target affinity prediction value. We conducted experiments on the Davis and Kiba datasets, and the experimental results showed that WPGraphDTA exhibited good prediction performance.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"18 Suppl 1","pages":"9"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730168/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Genomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12920-024-02073-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Drug and protein targets affect the physiological functions and metabolic effects of the body through bonding reactions, and accurate prediction of drug-protein target interactions is crucial for drug development. In order to shorten the drug development cycle and reduce costs, machine learning methods are gradually playing an important role in the field of drug-target interactions.

Results: Compared with other methods, regression-based drug target affinity is more representative of the binding ability. Accurate prediction of drug target affinity can effectively reduce the time and cost of drug retargeting and new drug development. In this paper, a drug target affinity prediction model (WPGraphDTA) based on power graph and word2vec is proposed.

Conclusions: In this model, the drug molecular features in the power graph module are extracted by a graph neural network, and then the protein features are obtained by the Word2vec method. After feature fusion, they are input into the three full connection layers to obtain the drug target affinity prediction value. We conducted experiments on the Davis and Kiba datasets, and the experimental results showed that WPGraphDTA exhibited good prediction performance.

基于功率图和word2vec的药物-靶标结合亲和力预测。
背景:药物和蛋白质靶点通过键合反应影响机体的生理功能和代谢作用,准确预测药物-蛋白质靶点相互作用对药物开发至关重要。为了缩短药物开发周期和降低成本,机器学习方法在药物-靶标相互作用领域逐渐发挥着重要作用。结果:与其他方法相比,基于回归的药物靶标亲和力更能代表药物的结合能力。准确预测药物靶点亲和力可以有效减少药物重靶向和新药开发的时间和成本。本文提出了一种基于功率图和word2vec的药物靶点亲和力预测模型(WPGraphDTA)。结论:在该模型中,通过图神经网络提取功率图模块中的药物分子特征,然后通过Word2vec方法获得蛋白质特征。特征融合后输入到三个全连接层中,得到药物靶点亲和力预测值。我们在Davis和Kiba数据集上进行了实验,实验结果表明WPGraphDTA具有良好的预测性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medical Genomics
BMC Medical Genomics 医学-遗传学
CiteScore
3.90
自引率
0.00%
发文量
243
审稿时长
3.5 months
期刊介绍: BMC Medical Genomics is an open access journal publishing original peer-reviewed research articles in all aspects of functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信